Home / Health / College Student Dies After Taking Weight Loss Drug
College Student Dies After Taking Weight Loss Drug
13 Aug
Summary
- A 19-year-old college student died after taking tirzepatide.
- Her death was attributed to cardiac arrhythmia, an abnormal heart rhythm.
- A pre-existing congenital heart condition may have contributed to the outcome.
A 19-year-old law student, Josephine Nasr, tragically passed away in her London dormitory room on September 23, 2025, shortly after taking tirzepatide, a widely used GLP-1 weight loss medication. Nasr, who was studying international law at the University of East London, had been prescribed Zepbound by a U.S. doctor and had been taking it since the summer of 2025.
Nasr reported experiencing vomiting and nausea to her family on the evening of her death. These are recognized side effects of GLP-1 drugs. Her sister arranged for IV fluids due to concerns about dehydration. Tragically, Nasr was found unresponsive in her bathroom approximately two hours after her last contact with her family, with an empty vial of the medication nearby.
An inquest held at East London Coroner's Court concluded that Nasr's death was due to cardiac arrhythmia. Pathologists identified a congenital heart condition, myocardial bridging, which may have been exacerbated by the vomiting and subsequent electrolyte imbalance caused by tirzepatide. While typically not life-threatening, the condition, combined with the drug's side effects, is believed to have contributed to the fatal outcome.
